Total Synthesis and Antimycobacterial Activity of Ohmyungsamycin A, Deoxyecumicin, and Ecumicin.
Full text not available from this repository.Item Type: | Article |
---|---|
Status: | Published |
Official URL: | https://doi.org/10.1002/chem.202002408 |
Journal or Publication Title: | Chemistry – A European Journal |
Volume: | 26 |
Number: | 66 |
Page Range: | pp. 15200-15205 |
Date: | 2020 |
Divisions: | Tuberculosis |
Depositing User: | General Admin |
Identification Number: | 10.1002/chem.202002408 |
ISSN: | 0947-6539 |
Date Deposited: | 04 Jan 2021 00:00 |
Abstract: | The ohmyungsamycin and ecumicin natural product families are structurally related cyclic depsipeptides that display potent antimycobacterial activity. Herein the total syntheses of ohmyungsamycin A, deoxyecumicin, and ecumicin are reported, together with the direct biological comparison of members of these natural product families against Mycobacterium tuberculosis (Mtb), the etiological agent of tuberculosis (TB). The synthesis of each of the natural products employed a solid‐phase strategy to assemble the linear peptide precursor, involving a key on‐resin esterification and an optional on‐resin dimethylation step, before a final solution‐phase macrolactamization between the non‐proteinogenic N‐methyl‐4‐methoxy‐l‐tryptophan amino acid and a bulky N‐methyl‐l‐valine residue. The synthetic natural products possessed potent antimycobacterial activity against Mtb with MIC90’s ranging from 110–360 nm and retained activity against Mtb in Mtb‐infected macrophages. Deoxyecumicin also exhibited rapid bactericidal killing against Mtb, sterilizing cultures after 21 days. |
Creators: | Creators Email Hawkins, Paige M. E. UNSPECIFIED Tran, Wendy UNSPECIFIED Nagalingam, Gayathri UNSPECIFIED Cheung, Chen‐Yi UNSPECIFIED Giltrap, Andrew M. UNSPECIFIED Cook, Gregory M. UNSPECIFIED Britton, Warwick J. UNSPECIFIED Payne, Richard J. UNSPECIFIED |
Last Modified: | 04 Jan 2021 00:00 |
URI: | https://eprints.centenary.org.au/id/eprint/824 |
Actions (login required)
![]() |
View Item |